Search

Free Shipping On All Orders Over $100
GET 20% OFF WHEN YOU SPEND $500 OR MORE

In Stock

Buy Tezspire (tezepelumab-ekko) Online

5 Reviews

DISEASE INDICATIONS: Asthma

MANUFACTURER: Amgen / AstraZeneca AB

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

 

Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

$6,696.25

Clear

Description

Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

Mechanism of Action

Tezspire works by blocking thymic stromal lymphopoietin (TSLP), a cytokine that plays a key role in the inflammatory cascade that leads to asthma symptoms. By blocking TSLP, Tezspire can help to reduce inflammation and improve lung function.

Dosage and Administration

Tezspire is given as a subcutaneous injection every four weeks. The recommended dosage for adults and children 12 years of age and older is 210 mg.

Effectiveness

Tezspire has been shown to be effective in reducing asthma exacerbations and improving lung function in clinical trials. For example, in one study, Tezspire reduced the rate of asthma exacerbations by 55% in patients with severe asthma.

Side Effects

The most common side effects of Tezspire include:

  • Headache
  • Nasopharyngitis
  • Upper respiratory tract infection
  • Arthralgia
  • Myalgia
  • Fatigue
  • Back pain
  • Diarrhea
  • Nausea
  • Rash

Tezspire can also cause serious side effects, such as:

  • Allergic reactions
  • Anaphylaxis
  • Injection site reactions
  • Eosinophilic pneumonia
  • Hypereosinophilia
  • Parasitic infections

Contraindications

Tezspire is contraindicated in patients with a known hypersensitivity to tezepelumab or any of the other ingredients in the medication.

Conclusion

Tezspire is an effective treatment for severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. It is important to be aware of the potential side effects of Tezspire before starting treatment. Talk to your doctor about the risks and benefits of Tezspire to determine if it is right for you.

Additional notes:

  • Tezspire should be used in conjunction with other asthma medications, such as inhaled corticosteroids and bronchodilators.
  • Tezspire is a new medication, and long-term safety data is not yet available.
  • Tezspire is expensive, and coverage may vary depending on your insurance plan.
Package

One single-dose syringe of 210 mg/1.91 mL (110 mg/mL)

Latest reviews

  1. CrystalRiverExplorer57

    Tezspire has made a meaningful difference in my overall well-being. I have more energy, fewer asthma symptoms, and a greater sense of control over my condition. My follow-up appointments have been consistently positive, and I’m grateful to have access to such an effective treatment option.

  2. Marco Bianchi

    Living with severe asthma was exhausting, but Tezspire has helped stabilize my condition. My flare-ups have decreased, and my breathing feels more predictable and manageable. My pulmonologist has been very satisfied with my response to treatment, and I finally feel more confident in my daily life.

  3. Emily Carter

    Tezspire has exceeded my expectations. Before treatment, I was constantly managing symptoms and avoiding triggers, but now I feel much more in control of my asthma. I can exercise more comfortably and don’t rely on rescue medication as often. My healthcare team is very pleased with my progress, and so am I.

  4. Hassan Al-Masri

    Since beginning Tezspire, my asthma symptoms have improved significantly. I have fewer nighttime awakenings, less wheezing, and better overall lung comfort. My doctor has been closely monitoring my response, and each visit has shown steady improvement. It’s been a huge relief to finally find something that works for me.

  5. Daniela Rossi

    Tezspire has made a noticeable difference in managing my severe asthma. I used to experience frequent flare-ups despite being on multiple inhalers, but those episodes have become much less common since starting treatment. My breathing feels more stable, and I can stay active without constantly worrying about sudden attacks. My pulmonologist has been very encouraged by my progress.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online

$755.34
(5 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma MANUFACTURER: GlaxoSmithKline USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA)   It is used for the management of chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by breathing difficulties, coughing, and wheezing. This medication is designed to provide comprehensive treatment for COPD by addressing various aspects of the disease.

Buy Symkevi (tezacaftor/ivacaftor) Online

$5,729.85
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.

Buy Yupelri (revefenacin) Online

(5 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease MANUFACTURER: Theravance Biopharma USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Yupelri is a pharmaceutical medication used to treat chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by difficulty breathing, coughing, and wheezing.

Buy Tezspire (tezepelumab-ekko) Online

$6,696.25
(5 Reviews)
DISEASE INDICATIONS: Asthma MANUFACTURER: Amgen / AstraZeneca AB USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online

From $39,106.10
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals Incorporated USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Trikafta is designed to address the underlying genetic mutations in individuals with CF and has been shown to significantly improve lung function and overall health in many patients.

Buy Orkambi (lumacaftor/ivacaftor) Online

From $10,806.14
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) This medication is designed to address the underlying cause of CF in individuals who have two copies of the F508del mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which is a common genetic mutation associated with CF.

Buy Symdeko (tezacaftor / ivacaftor) Online

$39,418.95
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

Back to Top
Product has been added to your cart